成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Yifei Biotechnology Co. , Ltd.??? ?? ??? ?????.

?? ?:Shanghai Yifei Biotechnology Co. , Ltd.
??:021-65675885
???:customer_service@efebio.com
??:China
URL: http://www.efebio.com
? ?? ?:11974

?? ????

Basroparib1858179-75-5C18H21F2N7O3
SU 5616186611-58-5C13H8ClNOS
Berberine ursodeoxycholate1868138-66-2
Propionic-2,2-d2 acid19136-91-5C3H4D2O2
Diprogulic acid??????????18467-77-1C12H18O7
PF-067612811854061-19-0C13H17NO6
BRD24921821669-43-5C20H18N4O2
Cofetuzumab1869928-62-0
JTV-519 fumarate1883549-36-7C29H36N2O6S
Cbz-B3A1884710-81-9C35H58N6O9
Mosunetuzumab1905409-39-3
Fmoc-aminooxy-PEG2-NH2190249-87-7C19H22N2O5
NTRC 0066-01817791-73-3C33H39N7O2
Linvencorvir1808248-05-6C29H35FN6O5S
Iruplinalkib1854943-32-0C29H38ClN6O2P
1,4-Dideoxy-1,4-epithio-D-ribitol190315-43-6C5H10O3S
NS1-IN-1181373-35-3C23H26N2O4
Aplindore Fumarate189681-71-8C22H22N2O7
CXCR2-IN-21838123-21-9C18H23ClN2O5S
Ezurpimtrostat hydrochloride1914148-73-4C25H32Cl2N4
Anticonvulsant agent 10 HCl1818253-48-3
Gantofiban????183547-57-1C21H29N5O6
Ursolic aldehyde19132-81-1C30H48O2
PF-066492981854061-16-7C16H22O5
PF-067370071863905-38-7C25H28F4N2O6
Talacotuzumab1826831-79-1
Naxitamab1879925-92-4
Rezivertinib1835667-12-3C27H30N6O3
hCYP3A4 Fluorogenic substrate 1186299-00-3C19H12FNO2
Cibisatamab1855925-27-7
EPZ0325971887193-58-9C20H23N7O
Iladatuzumab1906205-76-2
Enapotamab1912423-61-0
Smurf-1 modulator CMP Example 201825371-51-4C23H34N4O5
CXCR2 antagonist 8182498-30-2C14H13N3O5
SDH-IN-21823354-06-8C10H6F3NO
FFN 206 dihydrochloride1883548-88-6C12H15ClN2O2
GlyT1 Inhibitor 11820934-93-7C22H21N5O2
Azintuxizumab1826819-57-1
Gilvetmab1808081-43-7
N-Nitroso-N-methylaniline-d51821341-18-7C7H8N2O
NS-2710184220-36-8C22H20N4O
Zamaporvint1900754-56-4C21H16F3N7O
HDAC8-IN-20a1884231-52-0C15H15NO4
Tibulizumab1849636-24-3
Tinlarebant1821327-95-0C21H21F5N4O2
TAK-4181818252-53-7
EPZ0332941887195-17-6C20H22ClN7O
(Iso)-Rilmakalim184653-89-2
Tofimilast??????185954-27-2C18H21N5S
Dersalazine????188913-58-8C35H32N6O4
Idelalisib D51830330-31-8C22H18FN7O
Mirikizumab1884201-71-1
OPC-1678321883747-71-4C21H20ClF3N2O4
PB1188714-28-5
TRV-120027 acetate (1234510-46-3 free base)1824712-70-0
Zavondemstat1851412-93-5C26H29N3O3
STC314186295-19-2C13H25NaO32S7
EGFR-IN-871835666-87-9C28H33N7O2
L-161240183298-68-2C15H20N2O5
MMPP1895957-18-2C17H18O3
Fentiazac????18046-21-4C17H12ClNO2S
AY 771835734-92-3C21H32N4O4
(3S,4S)-PF-064599881858291-14-1C19H22ClN7O3
Lorundrostat1820940-17-7C24H33N7O2
CJJ3001807631-83-9C30H33N3
Tyrosinase-IN-121860779-42-5C16H12ClN3S
IACS-010759 hydrochloride1807523-99-4C25H26ClF3N6O4S
TBDMS-PEG4-Acid1807540-77-7C15H32O6Si
Duvortuxizumab1831098-91-9
Lesofavumab1807960-57-1
YNT-1851804978-81-1C33H37N5O5S
MLT-9851832576-25-6C17H15Cl2N9O2
Loncastuximab1875032-68-0
Setrusumab1847394-95-9
YNT-185 dihydrochloride1804978-82-2C33H38ClN5O5S
ZY-194891821293-40-6C24H32FN9
Trifluoromethyl-tubercidin1854086-05-7C12H13F3N4O4
Edralbrutinib1858206-58-2C26H21F2N5O3
TriGalNAc CBz186613-57-0C34H35NO11
Tisolagiline1894207-44-3C17H17F3N2O
Br-PEG4-THP1803547-60-5C13H25BrO5
FM041807320-40-6
Clenoliximab??????182912-58-9
cPrPMEDAP182798-83-0C11H17N6O4P
Cofrogliptin1844874-26-5C18H19F5N4O3S
Gatralimab1826020-80-7
Omburtamab1895083-75-6
Tislelizumab1858168-59-8
Lacnotuzumab1831128-32-5
Gedivumab1807954-17-1
3-phenylpropanoic-2,2-d2 acidHYDROCINNAMIC-2,2-D2?19136-97-1C9H8D2O2
NBI-279145-???-N-(?????????)-2-??-N-???-N'-(2,4,6-???????)-4,6-?????????????????(XNUMX-CHLORO-N-(CYCLOPROPYLMETHYL)-XNUMX-METHYL-N-PROPYL-N'-(XNUMX-TRICHLOROPHENYL)-XNUMX-PYRIMIDINEDIAMINEHYDROCHLORIDE)184241-44-9C18H20Cl4N4
(R)-CJ 11974187281-35-2
SMO-IN-21822355-27-0C25H25F4N5O2
Cis-22a1819366-84-1C24H30F3N3O2
Resomelagon1809420-71-0C14H14N6O2
HS941892594-93-2C15H15N5O2S
EM1271886879-71-5C14H18ClN3O3
Acloproxalap1824609-67-7C12H14N2O
Copyright 2019 ? ChemicalBook. All rights reserved